Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13046 | 864 | 44.7 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
478 | 3 | PHAGE DISPLAY//CELL FREE PROTEIN SYNTHESIS//ANTIBODY ENGINEERING | 23687 |
2154 | 2 | PHAGE DISPLAY//FILAMENTOUS BACTERIOPHAGE//MIMOTOPE | 5009 |
13046 | 1 | PHAGE DISPLAY//IN VIVO PHAGE DISPLAY//NGR HTNF | 864 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PHAGE DISPLAY | authKW | 518153 | 23% | 7% | 198 |
2 | IN VIVO PHAGE DISPLAY | authKW | 321274 | 1% | 91% | 10 |
3 | NGR HTNF | authKW | 294500 | 1% | 83% | 10 |
4 | NGR PEPTIDE | authKW | 271845 | 1% | 77% | 10 |
5 | ANTI NEOVASCULAR THERAPY | authKW | 247383 | 1% | 100% | 7 |
6 | IRGD | authKW | 213291 | 2% | 46% | 13 |
7 | PHAGE THER Y GRP | address | 212042 | 1% | 100% | 6 |
8 | LANDSCAPE PHAGE | authKW | 207876 | 1% | 59% | 10 |
9 | DAVID H KOCH | address | 193274 | 2% | 29% | 19 |
10 | LACTAPTIN | authKW | 181749 | 1% | 86% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1469 | 23% | 0% | 196 |
2 | Pharmacology & Pharmacy | 867 | 20% | 0% | 176 |
3 | Medicine, Research & Experimental | 652 | 11% | 0% | 97 |
4 | Biochemistry & Molecular Biology | 595 | 25% | 0% | 216 |
5 | Biochemical Research Methods | 332 | 7% | 0% | 64 |
6 | Cell Biology | 298 | 11% | 0% | 98 |
7 | Biotechnology & Applied Microbiology | 283 | 9% | 0% | 78 |
8 | Materials Science, Biomaterials | 106 | 2% | 0% | 18 |
9 | Chemistry, Multidisciplinary | 88 | 10% | 0% | 83 |
10 | Nanoscience & Nanotechnology | 76 | 4% | 0% | 36 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHAGE THER Y GRP | 212042 | 1% | 100% | 6 |
2 | DAVID H KOCH | 193274 | 2% | 29% | 19 |
3 | VASC M PING | 110425 | 1% | 31% | 10 |
4 | NOVEL DRUG SCREENING | 79514 | 0% | 75% | 3 |
5 | BIOPHARMACOL ANIM CELLS | 70681 | 0% | 100% | 2 |
6 | INTEGRATED FUNCT GENOM IZKF MUENSTER | 70681 | 0% | 100% | 2 |
7 | IIT NETWORK UNIT MOL NEUROSCI | 60575 | 1% | 29% | 6 |
8 | WRIGHT FLEMMING | 47119 | 0% | 67% | 2 |
9 | BURNHAM MED | 46483 | 1% | 13% | 10 |
10 | IMMUNOBIOTECHNOL UNIT | 45434 | 0% | 43% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CONTROLLED RELEASE | 5782 | 4% | 0% | 35 |
2 | JOURNAL OF DRUG TARGETING | 3820 | 2% | 1% | 13 |
3 | MOLECULAR PHARMACEUTICS | 3610 | 2% | 1% | 18 |
4 | INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS | 1626 | 1% | 1% | 5 |
5 | ADVANCES IN GENETICS | 1622 | 0% | 1% | 4 |
6 | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 1338 | 1% | 1% | 7 |
7 | MOLECULAR IMAGING AND BIOLOGY | 1313 | 1% | 1% | 6 |
8 | EXPERT OPINION ON DRUG DELIVERY | 1177 | 1% | 1% | 6 |
9 | BIOCONJUGATE CHEMISTRY | 1001 | 1% | 0% | 12 |
10 | AMINO ACIDS | 974 | 1% | 0% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PHAGE DISPLAY | 518153 | 23% | 7% | 198 | Search PHAGE+DISPLAY | Search PHAGE+DISPLAY |
2 | IN VIVO PHAGE DISPLAY | 321274 | 1% | 91% | 10 | Search IN+VIVO+PHAGE+DISPLAY | Search IN+VIVO+PHAGE+DISPLAY |
3 | NGR HTNF | 294500 | 1% | 83% | 10 | Search NGR+HTNF | Search NGR+HTNF |
4 | NGR PEPTIDE | 271845 | 1% | 77% | 10 | Search NGR+PEPTIDE | Search NGR+PEPTIDE |
5 | ANTI NEOVASCULAR THERAPY | 247383 | 1% | 100% | 7 | Search ANTI+NEOVASCULAR+THERAPY | Search ANTI+NEOVASCULAR+THERAPY |
6 | IRGD | 213291 | 2% | 46% | 13 | Search IRGD | Search IRGD |
7 | LANDSCAPE PHAGE | 207876 | 1% | 59% | 10 | Search LANDSCAPE+PHAGE | Search LANDSCAPE+PHAGE |
8 | LACTAPTIN | 181749 | 1% | 86% | 6 | Search LACTAPTIN | Search LACTAPTIN |
9 | TRUNCATED TISSUE FACTOR | 181749 | 1% | 86% | 6 | Search TRUNCATED+TISSUE+FACTOR | Search TRUNCATED+TISSUE+FACTOR |
10 | TUMOR HOMING PEPTIDES | 159029 | 1% | 75% | 6 | Search TUMOR+HOMING+PEPTIDES | Search TUMOR+HOMING+PEPTIDES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GRAY, BP , BROWN, KC , (2014) COMBINATORIAL PEPTIDE LIBRARIES: MINING FOR CELL-BINDING PEPTIDES.CHEMICAL REVIEWS. VOL. 114. ISSUE 2. P. 1020 -1081 | 213 | 37% | 45 |
2 | BROWN, KC , (2010) PEPTIDIC TUMOR TARGETING AGENTS: THE ROAD FROM PHAGE DISPLAY PEPTIDE SELECTIONS TO CLINICAL APPLICATIONS.CURRENT PHARMACEUTICAL DESIGN. VOL. 16. ISSUE 9. P. 1040 -1054 | 82 | 47% | 64 |
3 | BABICKOVA, J , TOTHOVA, L , BOOR, P , CELEC, P , (2013) IN VIVO PHAGE DISPLAY - A DISCOVERY TOOL IN MOLECULAR BIOMEDICINE.BIOTECHNOLOGY ADVANCES. VOL. 31. ISSUE 8. P. 1247 -1259 | 67 | 57% | 12 |
4 | D'ONOFRIO, N , CARAGLIA, M , GRIMALDI, A , MARFELLA, R , SERVILLO, L , PAOLISSO, G , BALESTRIERI, ML , (2014) VASCULAR-HOMING PEPTIDES FOR TARGETED DRUG DELIVERY AND MOLECULAR IMAGING: MEETING THE CLINICAL CHALLENGES.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1846. ISSUE 1. P. 1 -12 | 63 | 55% | 12 |
5 | GAUTAM, A , KAPOOR, P , CHAUDHARY, K , KUMAR, R , RAGHAVA, GPS , (2014) TUMOR HOMING PEPTIDES AS MOLECULAR PROBES FOR CANCER THERAPEUTICS, DIAGNOSTICS AND THERANOSTICS.CURRENT MEDICINAL CHEMISTRY. VOL. 21. ISSUE 21. P. 2367 -2391 | 78 | 39% | 16 |
6 | LI, ZJ , CHO, CH , (2012) PEPTIDES AS TARGETING PROBES AGAINST TUMOR VASCULATURE FOR DIAGNOSIS AND DRUG DELIVERY.JOURNAL OF TRANSLATIONAL MEDICINE. VOL. 10. ISSUE . P. - | 52 | 62% | 25 |
7 | DEUTSCHER, SL , (2010) PHAGE DISPLAY IN MOLECULAR IMAGING AND DIAGNOSIS OF CANCER.CHEMICAL REVIEWS. VOL. 110. ISSUE 5. P. 3196-3211 | 63 | 37% | 84 |
8 | TREPEL, M , PASQUALINI, R , ARAP, W , (2008) SCREENING PHAGE-DISPLAY PEPTIDE LIBRARIES FOR VASCULAR TARGETED PEPTIDES.ANGIOGENESIS: IN VIVO SYSTEMS, PT B. VOL. 445. ISSUE . P. 83-106 | 50 | 58% | 13 |
9 | CHEETHAM, AG , KEITH, D , ZHANG, PC , LIN, R , SU, H , CUI, HG , (2016) TARGETING TUMORS WITH SMALL MOLECULE PEPTIDES.CURRENT CANCER DRUG TARGETS. VOL. 16. ISSUE 6. P. 489 -508 | 73 | 31% | 0 |
10 | ZOU, MM , ZHANG, L , XIE, YC , XU, WF , (2012) NGR-BASED STRATEGIES FOR TARGETING DELIVERY OF CHEMOTHERAPEUTICS TO TUMOR VASCULATURE.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 12. ISSUE 3. P. 239 -246 | 35 | 63% | 9 |
Classes with closest relation at Level 1 |